Chueakwon, P.; Jatooratthawichot, P.; Talabnin, K.; Ketudat Cairns, J.R.; Talabnin, C.
Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway. Life 2022, 12, 351.
https://doi.org/10.3390/life12030351
AMA Style
Chueakwon P, Jatooratthawichot P, Talabnin K, Ketudat Cairns JR, Talabnin C.
Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway. Life. 2022; 12(3):351.
https://doi.org/10.3390/life12030351
Chicago/Turabian Style
Chueakwon, Piyasiri, Peeranat Jatooratthawichot, Krajang Talabnin, James R. Ketudat Cairns, and Chutima Talabnin.
2022. "Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway" Life 12, no. 3: 351.
https://doi.org/10.3390/life12030351
APA Style
Chueakwon, P., Jatooratthawichot, P., Talabnin, K., Ketudat Cairns, J. R., & Talabnin, C.
(2022). Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway. Life, 12(3), 351.
https://doi.org/10.3390/life12030351